Reading view
Exclusive eBook: How AGI Became a Consequential Conspiracy Theory
In this exclusive subscriber-only eBook, you’ll learn about how the idea that machines will be as smart as—or smarter than—humans has hijacked an entire industry.
by Will Douglas Heaven October 30, 2025
Table of Contents:
- How Silicon Valley got AGI-pilled
- The great AGI conspiracy
- How AGI hijacked an industry
- The great AGI conspiracy, concluded
Related Stories:
Access all subscriber-only eBooks:
Molecular features of early- vs. late-onset gastric cancer: a systematic review and meta-analysis
BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-026-15567-5. Online ahead of print.
ABSTRACT
BACKGROUND: Early-onset gastric cancer (EOGC), diagnosed before age 50, is characterized by distinct clinicopathological features, though its molecular landscape remains poorly defined.
METHODS: A systematic literature search of PubMed, Embase, and Web of Science identified studies comparing molecular characteristics of EOGC and late-onset gastric cancer (LOGC). Meta-analyses assessed differences in The Cancer Genome Atlas (TCGA) molecular subtypes, gene mutations, therapeutic biomarkers, and serum tumor markers. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated; heterogeneity was assessed using the I2 statistic.
RESULTS: EOGC was associated with a higher prevalence of the genomically stable (GS) subtype (OR = 1.71, 95% CI: 1.37-2.12) and a lower prevalence of the chromosomal instability (CIN) subtype (OR = 0.62, 95% CI: 0.50-0.77). CDH1 mutations were more frequent in EOGC (OR = 3.44, 95% CI: 2.85-4.16), while HER2 expression (OR = 0.54, 95% CI: 0.43-0.67), dMMR/MSI-H status (OR = 0.25, 95% CI: 0.12-0.53), and p53 expression (OR = 0.56, 95% CI: 0.39-0.82) were significantly lower. Serum markers including CEA and CA19-9 were also less frequently elevated in EOGC.
CONCLUSION: EOGC represents a biologically distinct subset of gastric cancer with unique genomic and immunological features. These findings support age-specific diagnostic approaches and emphasize the value of multiomic strategies to uncover the mechanisms driving early-onset disease.
PMID:41535782 | DOI:10.1186/s12885-026-15567-5
ART: Action-based Reasoning Task Benchmarking for Medical AI Agents
Human-AI Co-design for Clinical Prediction Models
PrivacyReasoner: Can LLM Emulate a Human-like Privacy Mind?
Companion Agents: A Table-Information Mining Paradigm for Text-to-SQL
Triples and Knowledge-Infused Embeddings for Clustering and Classification of Scientific Documents
AI Deployment Authorisation: A Global Standard for Machine-Readable Governance of High-Risk Artificial Intelligence
From Symbolic to Natural-Language Relations: Rethinking Knowledge Graph Construction in the Era of Large Language Models
A Marketplace for AI-Generated Adult Content and Deepfakes
Global Benchmark Database
Mitigating Gender Bias via Fostering Exploratory Thinking in LLMs
GI-Bench: A Panoramic Benchmark Revealing the Knowledge-Experience Dissociation of Multimodal Large Language Models in Gastrointestinal Endoscopy Against Clinical Standards
Regulatory gray areas of LLM Terms
Nationwide genetic screening proves effective at catching disease risk early
Nature, Published online: 15 January 2026; doi:10.1038/d41586-026-00035-8
A study in Australia supports genetic screening in young adults before symptoms show, but the generalizability and cost–benefit ratios need to be examined in other settings.Circulating metabolites, genetics and lifestyle factors in relation to future risk of type 2 diabetes
Nat Med. 2026 Jan 14. doi: 10.1038/s41591-025-04105-8. Online ahead of print.
ABSTRACT
The human metabolome reflects complex metabolic states affected by genetic and environmental factors. However, metabolites associated with type 2 diabetes (T2D) risk and their determinants remain insufficiently characterized. Here we integrated blood metabolomic, genomic and lifestyle data from up to 23,634 initially T2D-free participants from ten cohorts. Of 469 metabolites examined, 235 were associated with incident T2D during up to 26 years of follow-up, including 67 associations not previously reported across bile acid, lipid, carnitine, urea cycle and arginine/proline, glycine and histidine pathways. Further genetic analyses linked these metabolites to signaling pathways and clinical traits central to T2D pathophysiology, including insulin resistance, glucose/insulin response, ectopic fat deposition, energy/lipid regulation and liver function. Lifestyle factors-particularly physical activity, obesity and diet-explained greater variations in T2D-associated versus non-associated metabolites, with specific metabolites revealed as potential mediators. Finally, a 44-metabolite signature improved T2D risk prediction beyond conventional factors. These findings provide a foundation for understanding T2D mechanisms and may inform precision prevention targeting specific metabolic pathways.
PMID:41535386 | DOI:10.1038/s41591-025-04105-8
Multi-omics to study chronic respiratory diseases and viral infections
Eur Respir Rev. 2026 Jan 14;35(179):240286. doi: 10.1183/16000617.0286-2024. Print 2026 Jan.
ABSTRACT
Despite recent advances, the underlying mechanisms of the development and progression of many chronic respiratory diseases remain to be elucidated. Factors such as heterogeneity and complexity of human diseases and difficulty interpreting large datasets hinder research into chronic respiratory diseases. Omics assesses the changes in specific biological entities, such as mRNA expression, epigenetics/epigenomics, genomics, proteomics, metagenomics and metabolomics, and provides valuable insights into the roles of these processes in chronic respiratory diseases. High-throughput omics at bulk, single-cell and spatial levels empower the exploration of disease-related changes through untargeted data-driven statistical methods. Multi-omics is the exploration and integration of multiple biological processes, which compared to a single-omics, can provide a substantially greater and more holistic overview of the pathogenic mechanisms that underpin complex diseases. Multi-omics analysis can comprehensively characterise the mechanisms that drive chronic respiratory diseases, capturing unique biological signatures and cellular interactions at different omics levels. Use of these methods has begun to identify key factors and biomarkers in chronic respiratory diseases. Here, we review current omics approaches and highlight recent advances in respiratory research achieved using multi-omics and integrative methods. Our review provides a valuable resource for researchers and clinicians in this area.
PMID:41534886 | DOI:10.1183/16000617.0286-2024
Complement-secreting CAFs are associated with better prognosis in pancreatic cancer: single-cell multiomics
Gut. 2026 Jan 13:gutjnl-2025-335683. doi: 10.1136/gutjnl-2025-335683. Online ahead of print.
ABSTRACT
BACKGROUND: Accumulating evidence has demonstrated that distinct tumour-promoting and tumour-restraining cancer-associated fibroblast (CAF) subtypes coexist in pancreatic ductal adenocarcinoma.
OBJECTIVE: To develop targeted CAF therapeutic strategies by reprogramming tumour-promoting CAF subtypes.
DESIGN: We leveraged multiomics technologies to systematically identify and characterise CAF subtypes transcriptionally, epigenetically and spatially and correlate them with clinicopathological features.
RESULTS: We found that complement-secreting CAFs (csCAFs), initially identified by our group and inflammatory CAFs (iCAFs) share significant overlap in their transcriptional profiles and chromatin accessibility. iCAFs specifically express transcription factors from the heme and oxidative homeostasis pathway and the activator protein 1 family, which are both involved in cellular response to oxidative stress. Notably, the composition of csCAFs among all CAFs declined during pancreatic carcinogenesis, while trajectory analysis showed that csCAFs could potentially differentiate into iCAFs. Spatially resolved analysis indicated that tumour regions with a higher csCAF composition were associated with lower levels of TGF-β ligands, fewer M2 tumour-associated macrophages and increased levels of lipid mediators. Additionally, we identified a spatially defined CXCL12-CXCR4 ligand-receptor interaction between csCAFs and T cells, but in distinct patterns between different metastatic organs. Patients with a higher composition of csCAFs have significantly longer overall survival and recurrence-free survival through multiplex immunohistochemistry and bulk RNA-seq deconvolution.
CONCLUSION: Our study demonstrates that csCAFs may represent an early-stage iCAF subtype and suggests a promising strategy for reprogramming iCAFs into csCAFs.
PMID:41534892 | DOI:10.1136/gutjnl-2025-335683
Artificial intelligence tools expand scientists’ impact but contract science’s focus
Nature, Published online: 14 January 2026; doi:10.1038/s41586-025-09922-y
Artificial intelligence boosts individual scientists’ output, citations and career progression, but collectively narrows research diversity and reduces collaboration, concentrating work in data-rich areas and potentially limiting broader scientific exploration.